Sentinel Node Biopsy: From guidelines to practice | 5 hrs
Sentinel node biopsy (SNB) has revolutionised the management of melanoma patients through accurate staging and helping to guide therapeutic decision-making. Learning the subtleties of...
Melanoma awareness with Prof Richard Scolyer | 42 min
In this interview for the Derm Club Podcast, Pathologist Prof Richard Scolyer AO provides an overview of melanoma and the public health challenge we...
How to diagnose borderline cutaneous melanocytic lesions | 98 min
In this recorded webinar from pathCast, Pathologists Prof Richard Scolyer AO, A/Prof Andrew Dettrick and Dr Nigel Maher discuss: Background to borderline melanocytic lesions...
Neoadjuvant immunotherapy: Revolutionising melanoma treatment | 36 min
Our latest podcast explores the innovative approach of neoadjuvant immunotherapy – administering checkpoint inhibitor immunotherapy before the surgical removal of melanoma. This promising approach...
The role of PRAME immunohistochemistry in the diagnostic approach to melanocytic lesions | 30 min
PRAME is a tumour-associated antigen identified by autologous T-cell epitope in a patient with metastatic cutaneous melanoma. In this presentation Pathologist Dr Robert Rawson...
Unravelling lentigo maligna | 48 min
Lentigo maligna – a subtype of in situ melanoma – presents diagnostic and treatment challenges for clinicians. In this podcast, Dr Michael Rtshiladze leads...
The critical role of standardised pathological assessment in neoadjuvant therapy for melanoma: A guide for Pathologists | 40 min
The role of the Pathologist is crucial in the emerging field of neoadjuvant therapy in melanoma. Understanding that their role is fundamental to patient...
Diagnosis and management of uveal melanoma | 44 min
Despite recent advances in management of primary uveal melanoma, more than half of patients develop metastatic disease – often with poor outcomes. New therapeutic...
Refining pathological response assessment in neoadjuvant therapy for melanoma | 40 min
In this presentation, Pathologist Prof Richard Scolyer AO discusses how neoadjuvant therapy is transforming melanoma patient care. He also answers key questions around neoadjuvant-treated...